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In the developing heart, the epicardium is essential for coronary vasculogenesis as it provides precursor cells that become
coronary vascular smooth muscle and perivascular fibroblasts. These precursor cells are derived from the epicardium via
epithelial–mesenchymal transformation (EMT). The factors that regulate epicardial EMT are unknown. Using a quantitative
in vitro collagen gel assay, we show that serum, FGF-1, -2, and -7, VEGF, and EGF stimulate epicardial EMT. TGFb-1
timulates EMT only weakly, while TGFb-2 and -3 do not stimulate EMT. TGFb-1, -2, or -3 strongly inhibits transformation
f epicardial cells stimulated with FGF-2 or heart-conditioned medium. TGFb-3 does not block expression of vimentin, a
mesenchymal marker, but appears to inhibit EMT by blocking epithelial cell dissociation and subsequent extracellular
matrix invasion. Blocking antisera directed against FGF-1, -2, or -7 substantially inhibit conditioned medium-stimulated
EMT in vitro, while antibodies to TGFb-1, -2, or -3 increase it. We confirmed FGF stimulation and TGFb inhibition of
picardial EMT in organ culture. Immunoblot analysis confirmed the presence of FGF-1, -2, and -7 and TGFb-1, -2, and -3
n conditioned medium, and we localized these growth factors to the myocardium and epicardium of stage-appropriate
mbryos by immunofluorescence. Our results strongly support a model in which myocardially derived FGF-1, -2, or -7
romotes epicardial EMT, while TGFb-1, -2, or -3 restrains it. Epicardial EMT appears to be regulated through a different
ignaling pathway than endocardial EMT. © 2001 Academic Press
Key Words: epicardium; epithelial–mesenchymal transformation; FGF; TGFb; heart development; coronary
vasculogenesis.u
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The early embryonic heart consists of myocardium
which eventually is bordered by endocardium beneath and
epicardium above and is separated from each layer by
extensive extracellular matrix. The epicardium is derived
from the proepicardial organ, a derivative of the primordial
liver, at mouse embryonic day 9 and chick stage (HH) 15
(Hamburger and Hamilton, 1951; Viragh and Challice,
1981). The proepicardial organ deposits epicardial cells onto
the heart at the region of the atrioventricular groove. These
cells then migrate over the heart, ventrally and cephalad,
1 Present address: Department of Pediatrics, Northwestern Uni-
versity, Chicago, IL 60611.
2 To whom correspondence should be addressed. Fax: (415) 476-
a586. E-mail: jbristow@pedcard.ucsf.edu.
204ntil they completely cover the heart, covering the
onotruncus last by HH 28.
Coronary arteries and veins are assembled de novo from
ndothelial, coronary vascular smooth muscle, and pericyte
recursor cells in a vasculogenic process within the subepi-
ardial matrix (Mikawa and Gourdie, 1996; Viragh et al.,
993). The importance of the epicardium for coronary
asculogenesis is demonstrated by VCAM, alpha-4 integrin,
nd wilms tumor-1 null mice (Kwee et al., 1995; Moore et
l., 1999; Yang et al., 1995). These mice are deficient in
picardium and die with blood in the pericardial space at
12–E13, when coronary vasculogenesis is normally occur-
ing. We showed previously, by using transplantation of
acZ-labeled epicardial cells in quail–chick chimeras, that
picardial cells are the developmental precursors to coro-
ary vascular smooth muscle cells, as well as perivascular
nd intermyocardial fibroblasts, and that these cells are
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205FGFs Stimulate Epicardial–Mesenchymal Transformationderived from the epicardium through epithelial–
mesenchymal transformation (EMT) (Dettman et al., 1998).
picardial EMT has been confirmed by others
Gittenberger-de Groot et al., 1998; Landerholm et al., 1999;
erez-Pomares et al., 1998; Vrancken-Peeters et al., 1999).
ndothelial precursors migrate to the subepicardial space
ollowing the epicardium. The origin of these endothelial
ells has been postulated to be from the proepicardial organ
Poelmann et al., 1993); however, there is no evidence that
oronary vascular endothelial cells are derived directly from
he epicardium (Dettman et al., 1998; Vrancken-Peeters et
l., 1997, 1999).
EMT is a critical developmental process that evolved as a
eans of distributing cells from epithelia (Hay and Zuk,
995). It occurs in gastrulation, in organogenesis of the
idneys, lungs, gut, and heart, and in limb formation. TGFb
family members are important regulators of this process in
several systems, including the heart (Potts and Runyan,
1989; Proetzel et al., 1995; Runyan et al., 1992; Sun et al.,
1998; Taya et al., 1999). FGF-1, -2, and -7, while sometimes
implicated, have not been considered central to this process
(Chen et al., 1994; Landerholm et al., 1999; Mason et al.,
994; Valles et al., 1990). While several signaling molecules
nd transcription factors are associated with EMT (Hidai et
l., 1998; Lakkis and Epstein, 1998; Landerholm et al.,
999; Moore et al., 1999; Savagner et al., 1997), how these
several signaling pathways converge to regulate EMT re-
mains uncertain.
In the developing heart, EMT also occurs in the endocar-
dium, whereby endothelial cells give rise to mesenchyme
required for endocardial cushion morphogenesis. Endocar-
dial EMT occurs slightly before epicardial EMT and is
regionally restrictive: it is highly active around the atrio-
ventricular groove. Endocardial cells appear to become
primed for mesenchymal transformation by an unknown
factor secreted by the atrioventricular myocardium, not
FGF-2 but possibly TGFb-2 (Boyer et al., 1999a; Potts and
unyan, 1989; Runyan et al., 1992). The primed cells
ecrete TGFb-3, a factor that regulates endocardial EMT in
n autocrine fashion (Brown et al., 1996; Ramsdell and
Markwald, 1997). TGFb-3 requires the prior activity of
TGFb-2 to complete endocardial EMT (Nakajima et al.,
998).
The mechanisms that control epicardial EMT are un-
nown. Given the anatomic proximity of the myocardium
ith the endocardium and the epicardium in early cardiac
evelopment, we wondered whether TGFb family mem-
bers, particularly TGFb-3, and/or other growth factors pre-
iously implicated in EMT or vasculogenesis, might regu-
ate epicardial EMT.
MATERIALS AND METHODS
Collagen Gel Assay
Chick epicardial cell monolayers were grown on three-
dimensional collagen gels containing 95–98% collagen type I
Copyright © 2001 by Academic Press. All right(Vitrogen 100; Collagen Aesthetics, Palo Alto, CA) as described
(Dettman et al., 1998). We previously showed these monolayers to
be 97% epicardial cells and 3% endothelial cells. After 24 h, the
hearts were removed and the remaining epicardial monolayers
were washed twice with PBS and once with serum-free M199
medium. Monolayers were then grown for 60 h in M199 supple-
mented with one or more of the following growth factors:
rhTGFb-1 and -3, porcine TGFb-2, rhFGF-1, -2, and -7, rhEGF, and
hVEGF (R&D Systems), all at 10 ng/ml. Other monolayers were
ncubated with 10% (v/v) fetal bovine serum or serum-free medium
lone as positive and negative controls for EMT, respectively. Some
onolayers were stimulated with conditioned medium in combi-
ation with the above growth factors or blocking antibodies to
GFb-1, -2, and -3 or FGF-1, -2, and -7 (Santa Cruz) at 200 ng/ml
individually and in combination. Conditioned medium was col-
lected from nonadherent HH 22 avian hearts cultured in serum-free
medium for 2–4 days as a source of endogenous regulators of EMT.
After 60 h, the monolayers were fixed with fresh 4% (w/v)
paraformaldehyde or examined immediately with light micros-
copy. Mesenchymal transformation was defined as the invasion of
cells into the three-dimensional gels. The number of mesenchymal
cells per monolayer was counted manually by using an inverted
light microscope equipped with phase contrast or Hoffman modu-
lation optics.
Atrioventricular explants from HH 14 chick embryos were
isolated as described previously (Runyan et al., 1992) and were
ncubated on collagen gels prepared as for epicardial explants. After
he explants adhered to the gels (by 12 h), M199 and 10% fetal
ovine serum with and without rhTGFb-3 (10 ng/ml) or anti-
TGFb-3 (Santa Cruz) at 200 ng/ml was added. The explants were
incubated for an additional 60 h and EMT was observed as
described above. Samples in which the atrioventricular explants
stopped beating were discarded.
Immunocytochemistry
Epicardial monolayers were grown from explanted HH 22 hearts
atop glass coverslips coated with collagen (Vitrogen 100, Collagen
Aesthetics). The hearts were removed after 24 h and the monolay-
ers were washed twice with PBS and once with M199. Monolayers
were exposed to serum-free medium, conditioned medium, 10%
fetal bovine serum, or growth factors as above. After 48–72 h, the
monolayers were fixed with 4% PFA and then stained with
pan-cytokeratin (1:1000) (Dako) and vimentin (1:75) (Developmen-
tal Hybridoma Bank) for 1 h in blocking buffer [PBS, 0.1% (v/v)
Triton, 2.5% (w/v) BSA, and 2.5% (v/v) goat serum], followed by
appropriate FITC- or Texas Red-labeled secondary antibodies (1:
400) (Molecular Probes) for 1 h in blocking buffer. The cells were
analyzed with single-channel fluorescent microscopy. Images were
combined and processed electronically using SPOT software (v.
3.0.4, Diagnostic Instruments).
Immunofluorescence
HH 24 chick embryos were isolated in PBS and all membranes
were removed. The embryos were washed three times in PBS, fixed
in 4% PFA for 1 h on ice, and cryoprotected in 30% (w/v) sucrose
in 2% PFA overnight at 4°C. They were then immersed in OCT
before flash freezing in liquid nitrogen. Frozen sections were cut at
6-mm thickness and placed on Superfrost Plus slides (Fisher). After
air-drying at room temperature for 4 h, the sections were washed in
PBS three times to remove residual OCT and then incubated in
s of reproduction in any form reserved.
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206 Morabito et al.blocking buffer (as above) for 4–8 h. The sections were incubated
with antibodies to goat FGF-1, FGF-2, or FGF-7, rabbit TGFb-1,
GFb-2, and TGFb-3 (1:100) (Santa Cruz), or with an antibody to
atent TGFb-3 (1:100) [G-b3 (lat); Developmental Hybridoma
ank], followed by rabbit anti-goat FITC-labeled IgG (1:400)
Sigma), goat anti-rabbit, or goat anti-mouse Texas Red-labeled IgG
1:400) (Molecular Probes) as appropriate. The samples were ana-
yzed with Hoffman modulation optics (Nikon) and with single-
hannel immunofluorescence.
Immunoblotting
Serum-free medium, FGF-1, -2, and -7 and TGFb-1, -2, and -3,
nd heart-conditioned medium (100 ml per well) were transferred
nto a nitrocellulose membrane in 10 mM Tris–HCl, pH 8.2, and
0 mM NaCl under low continuous suction. The membrane was
locked for 4 h in blocking buffer consisting of 3% nonfat milk and
.5% BSA in TTBS [50 mM Tris–HCl, pH 7.5, 100 mM NaCl, 0.1%
v/v) Tween]. The membrane was cut into strips and each strip was
ncubated individually with respective anti-TGFb-1, -2, and -3 or
FGF-1, -2, and -7 antibodies (1:500) (Santa Cruz) overnight at room
temperature in blocking buffer. The strips were then washed for 2 h
in TTBS. Finally, the strips were incubated with HRP-goat anti-
rabbit IgG (Zymed) or rabbit anti-goat peroxidase conjugate (Sigma)
(1:15,000) as appropriate in blocking buffer for 45 min. Chemilu-
minescence was achieved with SuperSignal West Pico (Pierce) over
5 min. The blots were then exposed to RX film (Fuji) and developed.
Organ Culture
HH 28 avian embryos were isolated in serum-free medium under
sterile conditions. Pericardial sacs were opened to expose the
epicardia. The embryos were incubated in serum-free medium
containing carboxyfluorescein (CCFSE; Molecular Probes) diluted
1:200 for 1 h at 37°C. The hearts were then excised and placed in
serum-free medium or medium containing 10% FBS or 10 ng/ml of
TGFb-1, -2, and -3 or FGF-1, -2, or -7. The hearts were incubated at
37°C for 72 h, then fixed in fresh 4% PFA. The medium was
replaced every 24 h until fixation. The fixed hearts were dehydrated
into Hemo-D (Fisher), embedded in paraffin, and cut into 6-mm
sections. The hearts were examined by fluorescence microscopy.
Statistical Analysis
Mesenchymal cells per monolayer were counted manually. Av-
erages were calculated and compared using Student’s t test for two
variable comparisons and ANOVA for multiple comparisons with
the assistance of InStat software.
RESULTS
Growth Factor Regulation of EMT
The observation that epithelial cells undergo mesenchy-
mal transformation within a collagen matrix in vitro has
been well documented (Greenburg and Hay, 1982), and the
collagen gel assay has become the standard for the study of
EMT in vitro (Potts and Runyan, 1989). We previously
found that an epithelial epicardial monolayer can be grown
in serum-free medium on collagen gels from explanted
Copyright © 2001 by Academic Press. All rightbeating HH 22–24 avian hearts (Dettman et al., 1998). Once
the hearts are removed, an epicardial monolayer remains on
FIG. 1. Epithelial–mesenchymal transformation in vitro. (A) A nor-
mal, control epicardial epithelium grown on a three-dimensional
collagen gel viewed with Hoffman modulation optics. With these
optics, the nuclei are clearly visible, but the epithelial cell membranes
are difficult to visualize. (B) Deep into the gel, no mesenchymal cells
have invaded. Air bubbles have been trapped within the gel and can be
seen in this micrograph. (C) After stimulation of an epicardial mono-
layer with 10% fetal bovine serum, mesenchymal cells are seen
within the collagen gel. Shadows of epicardial cells in monolayer
above these mesenchymal cells are seen. (D) A low-power micrograph
of monolayer that demonstrates the effect of TGFb-2 or TGFb-3. The
epicardial monolayer is contracted. No mesenchymal cells were seen
within the gel (not shown). The bar represents 10 mm in (A–C) and 50
mm in (D).the surface of the collagen. Unstimulated epicardial cells
s of reproduction in any form reserved.
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207FGFs Stimulate Epicardial–Mesenchymal Transformationremain atop the collagen gel and retain their epithelial
phenotype (Fig. 1A). Figure 1B shows the collagen gel devoid
FIG. 2. Growth factor regulation of epicardial–mesenchymal transfor-
mation. Epicardial monolayers were treated with the indicated growth
factors or antisera and the number of mesenchymal cells per monolayer
was counted. Each bar represents the mean 6 at least SEM of five
independent experiments. (A) Monolayers stimulated with growth factor
(GF) alone. (B) Epithelia incubated with FGF-2 plus TGFb-1,- 2, or -3. (C)
onditioned medium (CM) plus GFs. (D) Conditioned medium stimu-
ated epithelia grown in the presence of blocking antibodies (Ab). SFM is
erum-free medium FBS is fetal bovine serum. *Statistically sig-
ificant (P , 0.05) compared to SFM. F, statistically significant
(P , 0.05) compared to CM.of cells immediately below an unstimulated epicardium.
Copyright © 2001 by Academic Press. All rightells stimulated with serum begin to dissociate from the
pithelium and invade the collagen matrix below the epi-
helial monolayer (Fig. 1C). The invading cells have an
longated shape, typical of mesenchymal appearance, and
re found in multiple focal planes beneath the monolayer.
In order to quantitate the effects of various growth factors
nd conditions on epicardial–mesenchymal transformation,
e counted the number of mesenchymal cells derived from
ach monolayer. A similar method of quantifying EMT has
een used to study endocardial EMT (Boyer et al., 1999b;
akajima et al., 1998). Figure 2A shows the number of
esenchymal cells derived from epicardial monolayers
timulated with a variety of growth factors. Monolayers
ultured in the absence of serum typically produced fewer
han five mesenchymal cells per monolayer. Serum or
FIG. 3. Endocardial–mesenchymal transformation. (A) An HH 14
atrioventricular explant grown in M199 containing 10% serum
atop a collagen gel (arrowheads). Several mesenchymal cells have
left the explant and invaded the gel. (B) A similar explant incubated
in the presence of TGFb-3 antiserum (200 ng/ml). No cells have
invaded the gel matrix. (C) An explant grown in presence of
rhTGFb-3 (10 ng/ml). Numerous mesenchymal cells are seen
within the gel.
s of reproduction in any form reserved.
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208 Morabito et al.heart-conditioned medium stimulates large numbers of
cells to enter the gel. Addition of FGF-1, -2, or -7 produces
maximal stimulation of EMT. EGF and VEGF stimulate
EMT, but to a lesser degree than the FGFs.
Remarkably, TGFb family members have a quite differ-
nt effect on epicardial monolayers. TGFb-1 alone weakly
stimulates EMT, whereas TGFb-2 and -3 do not stimulate
MT when compared with serum-free medium (Fig. 2A).
onolayers incubated with TGFb-2 or -3 are contracted
Fig. 1D) and no mesenchymal cells are seen within the
ollagen gel. If these monolayers are left in culture for 4
ays, the entire monolayer lifts off the underlying collagen
el.
Given that TGFb family members do not appear to
timulate epicardial EMT, we wondered whether these
rowth factors might in fact be inhibitory. To test this
ypothesis, we studied the effects of TGFb-1, -2, and -3 on
picardial monolayers stimulated with FGF-2. We incu-
ated epicardial monolayers with FGF-2 (10 ng/ml) in
ombination with TGFb-1, -2, or -3 (10 ng/ml) for 72 h and
counted mesenchymal cells as above. During this time,
monolayers remained in contact with the collagen gels and
were morphologically indistinguishable from untreated
monolayers. Remarkably, these epithelia displayed no mes-
enchymal transformation, similar to serum-free medium-
FIG. 4. Immunoblot analysis of conditioned medium. Serum-fre
dilution), and FGF-1, -2, and -7 and TGFb-1, -2, and -3 (0.1, 1, an
ecognizing each growth factor. The first two columns show wells in
o immunoreactive material. Conditioned medium appears to con
resent at 1–10 ng/ml.treated controls (Fig. 2B). Thus, TGFbs appear to inhibit
Copyright © 2001 by Academic Press. All rightGF-2-stimulated mesenchymal transformation. To our
nowledge, this is the first demonstration of negative
egulation of EMT in any system.
In the next set of experiments, we tested how these
rowth factors alter EMT stimulated by conditioned me-
ium, which we consider to be a source of those factors that
ormally regulate EMT in vivo. As shown in Fig. 2C, the
ddition of FGF-1, -2, or -7 to conditioned medium produces
aximal levels of EMT, similar to FGFs alone. Importantly,
GFb-1, -2, or -3 restrains conditioned medium-stimulated
MT by .50%, suggesting that TGFbs inhibit the endoge-
ous stimulators of EMT.
To test whether the effect of conditioned medium on
xplants results from a balance of FGFs and TGFbs, we
locked the actions of FGF-1, -2, and -7 and TGFb-1, -2, and
3 by adding growth factor-specific antisera to conditioned
edium. In a preliminary experiment, we found that 200
g/ml of antibody was the minimum concentration neces-
ary to inhibit the effect of the exogenous growth factors.
efore proceeding, we also demonstrated that specific TGFb
and FGF antibodies blocked the activity of the cognate
growth factor, but not other family members (data not
shown). Figure 2D shows that antibodies to FGF-1, -2, and
-7 alone and in combination decrease epicardial–
mesenchymal transformation induced by conditioned me-
edium (SFM), conditioned medium (100 ml neat, 1:10 and 1:100
ng) were spotted onto nitrocellulose and blotted with antiserum
ted with secondary antibodies alone. Serum-free medium contains
at least 10 ng/ml of each growth factor, except TGFb-1, which ise m
d 10
cuba
taindium. As anticipated, antibodies to TGFb-1, -2, and -3 alone
s of reproduction in any form reserved.
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209FGFs Stimulate Epicardial–Mesenchymal Transformationand in combination increase conditioned medium-
stimulated epicardial–mesenchymal transformation to
FIG. 5. Localization of FGFs and TGFbs in stage 24 hearts. Immu
n the epicardium and the myocardium of HH 24 hearts. The p
rominent in both the epicardium and myocardium, and FGF-1
picardium. TGFb-3 is present in the myocardium, but has patchy
he rim of myocardium directly adjacent to the subepicardial m
myocardium. Ep, epicardium; Myo, myocardium; and En, endocarmaximal levels seen. These data provide direct evidence
Copyright © 2001 by Academic Press. All righthat FGFs and TGFbs are important regulators of endoge-
nous epicardial EMT.
orescence staining demonstrates the presence of FGF-1, -2, and -7
on the right are corresponding light images. FGF-2 is strongly
-7 are present in the myocardium but heterogeneously in the
ing in the epicardium. There is strong staining of latent TGFb-3 in
x (arrows), indicating that TGFb-3 is actively produced in the
.noflu
anels
and
stainFinally, to ensure that our TGFb reagents are comparable
s of reproduction in any form reserved.
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210 Morabito et al.to those previously used in studies of endocardial–
mesenchymal transformation, we analyzed the effects of
our TGFb-3 (10 ng/ml) and anti-TGFb-3 (200 ng/ml) on
ndocardial atrioventricular explants (Fig. 3). As expected,
nti-TGFb-3 inhibits (Fig. 3B) and exogenous TGFb-3
timulates (Fig. 3C) endocardial–mesenchymal transforma-
ion. This experiment demonstrates that essential differ-
nces exist between epicardial and endocardial EMT.
Growth Factor Localization
While the effects of FGFs and TGFbs on epicardial EMT
are dramatic, these in vitro studies alone do not prove a role
for these growth factors in the regulation of endogenous
epicardial EMT. We therefore documented the presence of
FGF-1, -2, and -7 and TGFb-1, -2, and -3 in conditioned
edium of stage 22 hearts by using a semiquantitative
mmunoblot analysis. As Fig. 4 shows, not only are each of
hese growth factors present in conditioned medium, but
heir concentration in conditioned medium appears to be
reater than the amount of recombinant growth factors
sed in these experiments.
We confirmed the presence of FGFs and TGFbs in the
eveloping heart at stage 24 (when EMT is active) by using
mmunofluorescence (Fig. 5). FGF-2 is prominent in both
he epicardium and the myocardium. FGF-1 and -7 are
resent in the myocardium, but only weakly in the epicar-
FIG. 6. Epicardial EMT in situ. (A) CCFSE-labeled epicardium fro
he epicardium is brightly stained and there is no subepicardial st
C) (10% FBS) and (D) (FGF-2) show many epicardially derived i
TGFb-3) show intact epicardia with rare CCFSE-labeled mesenchium. TGFb-3 is found in the myocardium and epicardium,
Copyright © 2001 by Academic Press. All rightbut heterogeneously. The distribution of TGFb-1 and -2 is
similar to that of TGFb-3 (data not shown). An antibody to
atent TGFb-3, the precursor to the extracellular, active
form of TGFb-3, demonstrates that the rim of myocardium
directly adjacent to the epicardium and the subepicardial
matrix produces TGFb-3, which presumably diffuses to the
epicardium after activation.
Epicardial–Mesenchymal Transformation in Situ
To extend these observations in a more physiologic
model, we developed an organ culture system to study the
effects of these growth factors on EMT in situ. Carboxy-
fluorescein (CCFSE) is a vital dye that is rapidly taken up by
cells, does not diffuse past basement membranes, and is
incorporated in daughter cells. CCFSE is stable during
paraformaldehyde fixation, paraffin embedding, and subse-
quent sectioning. It is therefore a useful tool for the study of
EMT (Griffith and Hay, 1992; Sun et al., 1998). HH 28
hearts were chosen because, at this stage, the epicardium
has covered most of the heart and distinct coronary vessels
have not yet formed. Figure 6 shows photomicrographs of
hearts exposed to CCFSE. Figure 6A shows a heart exposed
to CCFSE for 1 h in vivo, then fixed immediately. Distinct
staining of the epicardium is seen, but no staining of the
endocardium or of cells within the myocardium is evident.
Figures 6B–6F show hearts incubated either in serum-free
eart stained with CCFSE for 1 h in vivo, fixed, and photographed.
g. (B) A heart stimulated with serum-free medium alone for 72 h.
yocardial mesenchymal cells (arrowheads). (E) (TGFb-1) and (F)
cells.m a h
ainin
ntermmedium or with growth factors for 72 h. The media were
s of reproduction in any form reserved.
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211FGFs Stimulate Epicardial–Mesenchymal Transformationchanged every 24 h to prevent the hearts from conditioning
their own media. As these photomicrographs show, many
CCFSE-positive cells are seen in the myocardium of those
hearts exposed to FGF-1, -2, and -7 and serum and condi-
tioned medium. Rarely, a CCFSE-positive mesenchymal
cell is seen under control and TGFb-stimulated conditions.
he observation that epicardial EMT is stimulated by FGFs
ut inhibited by TGFbs in the epicardium’s natural envi-
onment confirms a regulatory role for these growth factors
n vivo.
Cytokeratin to Vimentin Switch
Two distinct phases of EMT have been described. First,
epithelial cells separate from each other, concomitant with
desmosome dissociation. Following separation, the cells
switch their cytoskeletal filaments, assume a mesenchymal
appearance, and become motile (Hay and Zuk, 1995; Ro-
mano and Runyan, 1999, 2000; Savagner et al., 1997). In
vitro, TGFb-3 produces profound changes in epicardial
monolayers that are best interpreted as persistence of cell–
cell contacts and loss of cell–matrix contacts (Fig. 1D). We
wondered whether TGFb-3 also inhibits the cytoskeletal
witch that is the hallmark of EMT. We therefore looked for
he incorporation of vimentin into the cytoskeleton of
picardial cells stimulated with TGFbs and FGFs as a
ytochemical marker of mesenchymal transformation.
onolayers grown in vitro were examined with double
mmunofluorescence for pan-cytokeratin and vimentin ex-
ression (Fig. 7). Figure 7A is an epicardial monolayer
ncubated in serum-free medium. The cells are cytokeratin-
ositive and vimentin-negative. The cells demonstrate a
ormal epithelial phenotype. Monolayers stimulated with
GFb-3 (Fig. 7C) are cytokeratin-positive and remain
imentin-negative. On the other hand, monolayers stimu-
ated with serum (Fig. 7B), conditioned medium, or FGF-2
Fig. 7D) are cytokeratin- and vimentin-positive. The cells
t the edge of the monolayer have begun to dissociate from
ach other and demonstrate a typical mesenchymal cell
hape, fulfilling the generally accepted requirements for
MT (Hay and Zuk, 1995). Figure 7E shows epicardial cells
ncubated in the presence of TGFb-3 and FGF-2. These cells
re also cytokeratin- and vimentin-positive, but have not
eparated from each other or migrated from the monolayer.
his suggests that TGFb-3 does not inhibit the early mo-
lecular program of EMT, but rather inhibits EMT by pre-
venting cell separation and cell motility.
DISCUSSION
Epicardial EMT is essential for the contribution of cells
that participate in the de novo assembly of blood vessels
within the subepicardial matrix (Dettman et al., 1998). The
resent study shows in a qualitative and quantitative fash-
on that FGF family members stimulate epicardial EMT and
hat TGFbs inhibit it. Our results are in stark contrast to t
Copyright © 2001 by Academic Press. All rightfindings for the endocardium, where TGFbs appear to be the
rimary stimulants of EMT (Brown et al., 1996; Nakajima
et al., 1998; Potts and Runyan, 1989; Proetzel et al., 1995;
Ramsdell and Markwald, 1997; Runyan et al., 1992; Sun et
al., 1998; Taya et al., 1999). Hence, it appears that epicardial
MT is regulated differently than endocardial EMT. De-
pite the spatial proximity of the two processes, this is not
urprising given the many differences between subsequent
oronary vascular development and endocardial cushion
orphogenesis.
In this study, 3 of the 21 known FGFs (Nishimura et al.,
000) were shown to stimulate epicardial–mesenchymal
ransformation to an almost equal degree in vitro. FGF-1, -2,
nd -7 are shown to be present in heart-conditioned me-
ium and antibodies to these factors individually and in
ombination significantly decrease conditioned-medium-
timulated EMT. In our collagen gel assay and organ cul-
ure, epicardial cells cultured in the presence of the FGFs,
erum, or conditioned medium incorporate vimentin into
heir cytoskeleton, assume a mesenchymal appearance, and
nvade subepithelial matrix.
We chose to limit our studies to these three FGFs because
hey have been implicated previously in EMT and because
hey have been identified as potent ligands for each of the
our known FGF receptors (although FGF-7 binds preferen-
ially to FGFR-2) (Chen et al., 1994; Mason et al., 1994;
Ornitz et al., 1996; Valles et al., 1990). FGF-1 and FGF-2
ull mice and FGF-1, -2 double null mice are morphologi-
ally normal and have normal cardiac development (Dono
t al., 1998; Ortega et al., 1998; Schultz et al., 1999; Zhou et
l., 1998). The lack of coronary vascular defects in these
ice, coupled with the finding that at least three FGFs are
ecreted by HH 22 hearts, implies functional redundancy
mong the FGFs. While the coexpression of FGF-1, -2, and
7 shown here may be sufficient to support EMT, FGF
amily members other than those we tested may also play a
ole in epicardial EMT in vivo.
Since myocardially secreted TGFb-2 and -3 have been
shown to be potent stimulators of endocardial EMT, we
were somewhat surprised to find that TGFb family mem-
ers restrain epicardial EMT. All three TGFbs dramatically
reduce EMT stimulated by conditioned medium or FGFs
and anti-TGFb antisera increase conditioned-medium-
stimulated EMT in vitro. Interestingly, TGFbs do not
prevent vimentin induction by FGF-2. These results taken
together suggest that TGFb restrains EMT by inhibiting cell
motility and subepithelial invasion.
To our knowledge, this is the first study demonstrating
that TGFbs simultaneously stimulate and inhibit similar
evelopmental mechanisms in the same organ. Indeed, the
ction of TGFb in these experiments is the first example of
negative regulation of EMT. Intracellular signaling after
TGFb ligand binding is dependent on Smad proteins, which
ransduce signals directly to the nucleus. Smad proteins
lone or complexed with the homeodomain protein TGIF or
istone deacetylases may be either stimulatory or inhibi-
ory (Heldin et al., 1997; Wotton et al., 1999). At this point,
s of reproduction in any form reserved.
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212 Morabito et al.the roles of stimulatory and inhibitory Smads in epicardial
EMT remain unexplored.
Given our results, we suggest a model of epicardial EMT
in which FGFs and TGFbs have opposing regulatory roles
Fig. 8). These growth factors are present in the epicardium
nd myocardium of the developing heart when epicardial
MT is active. Because these growth factors are secreted,
mmunofluorescence is not sufficient for identifying with
FIG. 7. Remodeling of epicardial cytoskeleton in mesenchymal tra
TGFb-3 (C) express cytokeratin (red) but not vimentin (green, a m
serum (B) and FGF-2 (D) express both cytokeratin and vimentin. (E)
ells are vimentin-positive, but retain their epithelial phenotype: t
taining of cytokeratin and vimentin is shown. (F) A monolayer stertainty the source of the growth factors. However, i
Copyright © 2001 by Academic Press. All rightGFb-3 does appear to be produced in the myocardium
irectly adjacent to the epicardium, as demonstrated by the
trong staining for latent TGFb-3 in the rim of myocardium
irectly adjacent to the subepicardial matrix. We postulate
hat TGFb-3 exerts a paracrine effect on epicardial cells,
ignaling cells not to undergo EMT and retaining them in
he epicardium. Myocardially secreted FGFs-1, -2, and -7
timulate epicardial cells to begin the process of EMT,
rmation. Epicardial cells incubated with serum-free medium (A) or
of mesenchymal transformation). Epicardial cells incubated with
nolayer incubated with TGFb-3 and FGF-2 under high power. The
lls have not separated from each other or become motile. Distinct
with secondary antibodies alone.nsfo
arker
A mo
he cencluding incorporating vimentin into the cytoskeleton.
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213FGFs Stimulate Epicardial–Mesenchymal TransformationThe prominence of FGF-2 staining in the epicardium sug-
gests that FGF-2 regulates EMT in vivo in both paracrine
nd autocrine fashions. Thus, primed epicardial cells may
roduce and secrete FGF-2 as they separate from each other
nd invade the subepicardial matrix to become mesen-
hyme. Autocrine signaling by FGF-2 during epithelial–
esenchymal transformation has been reported previously
Chen et al., 1994). Epicardially derived mesenchymal cells
ubsequently differentiate into pericytes, CVSMCs, or in-
ermyocardial fibroblasts. The signals controlling these cell
ate determinations are unknown.
Our data support opposing roles for FGF and TGFb
signaling pathways in the regulation of epicardial EMT, an
essential early step in coronary vessel formation. Under-
standing the molecular mechanisms that control epicardial
EMT may yield important insights into coronary vascular
FIG. 8. Model of epicardial–mesenchymal transformation. Epicard
by TGFbs. Myocardially secreted FGFs stimulate epicardial cells t
anner, stimulated cells produce FGF-2 as they separate from the
BM), invades the subepithelial matrix, and becomes a mesenchy
detachment from the epithelium. Yet undefined signals stimulate t
muscle cells (CVSMC), perivascular fibroblasts (PeriF), or intermy
assemble around an endothelial cell (En) to form a nascent coronadevelopment and remodeling in disease states.
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